Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ASTRAZENECA PHARMA Gains 13%; BSE HEALTHCARE Index Up 0.5%
Tue, 23 Jul 14:39

ASTRAZENECA PHARMA Gains 13%; BSE HEALTHCARE Index Up 0.5%Image source: phive2015/www.istockphoto.com

ASTRAZENECA PHARMA share price has zoomed 13% and is presently trading at Rs 7,044.0.

Meanwhile, the BSE HEALTHCARE index is at 38,689.6 (up 0.5%).

Among the top gainers in the BSE HEALTHCARE index today are Pfizer (up 3.1%) and GSK Pharma (up 3.0%).

ALEMBIC PHARMA (down 2.8%) and LAURUS LABS (down 2.5%) are among the top losers today.

Over the last one year, ASTRAZENECA PHARMA has moved up from Rs 3,805.5 to Rs 7,044.0, registering a gain of Rs 3,238.5 (up 85.1%).

On the other hand, the BSE HEALTHCARE index has moved up from 26,477.4 to 38,689.6, registering a gain of 46.1% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Glenmark Pharma (up 97.4%), Lupin (up 92.8%) and GSK Pharma (up 92.4%).

Dear Reader: If You Invest in Midcap Stocks, this is for You

What About the Benchmark Indices?

The BSE Sensex is at 80,452.7 (down 0.1%).

The top losers among the BSE Sensex today are L&T (down 3.5%) and Bajaj Finance (down 2.0%). The most traded stocks in the BSE Sensex are Tata Steel and NTPC.

In the meantime, NSE Nifty is at 24,494.4 (down 0.1%). L&T and Hindalco are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 67,097.4 to 80,452.7, registering a gain of 13,355.2 points (up 19.9%).

ASTRAZENECA PHARMA Financial Update...

ASTRAZENECA PHARMA net profit grew 128.6% YoY to Rs 395 million for the quarter ended March 2024, compared to a profit of Rs 173 million a year ago. Net sales rose 34.6% to Rs 3,832 million during the period as against Rs 2,847 million in January-March 2023.

For the year ended March 2024, ASTRAZENECA PHARMA reported 62.7% increase in net profit to Rs 1,615 million compared to net profit of Rs 993 million during FY23. Revenue of the company grew 29.2% to Rs 12,955 million during FY24.

The current Price to earnings ratio of ASTRAZENECA PHARMA, based on rolling 12 month earnings, stands at 109.0.


Equitymaster requests your view! Post a comment on "ASTRAZENECA PHARMA Gains 13%; BSE HEALTHCARE Index Up 0.5%". Click here!